Stock 1498 PURAPHARM CORPORATION LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company PuraPharm Corporation Limited

Equities

1498

KYG7306Y1044

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:15 2024-04-18 am EDT 		5-day change 1st Jan Change
0.74 HKD -2.63% Intraday chart for PuraPharm Corporation Limited -8.64% -17.78%
Apr. 01 PuraPharm's Net Loss Shrinks in 2023; Revenue Falls 9% MT
Mar. 28 PuraPharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

PuraPharm Corporation Ltd is an investment holding company principally engaged in the concentrated Chinese medicine granule (CCMG) businesses. The Company operates through five business segments. The China CCMG segment is mainly engaged in the production and sales of CCMG products in China. The Hong Kong CCMG segment is mainly engaged in the sales of CCMG products, excluding the sales through self-operated clinics in Hong Kong. The Chinese Healthcare Products segment is mainly engaged in the production and sales of healthcare products in Hong Kong and China. The Clinics segment is mainly engaged in the provision of Chinese medical diagnostic services and sales of CCMG products through self-operated clinics. The Plantation segment is mainly engaged in the plantation and trading of raw Chinese herbs, and the manufacture and sale of traditional Chinese medicine (TCM) decoction pieces.

Number of employees: 662

Sales per Business

HKD in Million2021Weight2022Weight Delta
Hong Kong Concentrated Chinese Medicine Granules
42.9 %
163 24.7 % 192 42.9 % +18.04%
China Concentrated Chinese Medicine Granules
26.3 %
353 53.5 % 118 26.3 % -66.64%
Chinese Healthcare Products
17.6 %
78 11.8 % 79 17.6 % +0.97%
Clinics
10.3 %
50 7.6 % 46 10.3 % -7.83%
Plantation
3.0 %
16 2.4 % 13 3.0 % -15.75%

Sales per region

HKD in Million2021Weight2022Weight Delta
Hong Kong
62.8 %
242 36.8 % 282 62.8 % +16.11%
China
29.5 %
374 56.7 % 132 29.5 % -64.63%
Other Countries/Regions
7.6 %
43 6.5 % 34 7.6 % -20.43%

Managers

Managers TitleAgeSince
Yu Ling Chan CEO
 Chief Executive Officer 63 98-05-04
Hang Woon Ma SAM
 Sales & Marketing - -
Pui Hung HRO
 Human Resources Officer - -
Kwun Kiu Cheung AUD
 Comptroller/Controller/Auditor 38 20-12-31
Yuk Chun Ho SAM
 Sales & Marketing 56 04-12-31
Qiong Ruan PRN
 Corporate Officer/Principal 46 -
Charmayne Chan SEC
 Corporate Secretary - 21-07-30

Members of the board

Members of the board TitleAgeSince
Kwok Wah Ho BRD
 Director/Board Member 65 15-06-11
Lim Kin Leung BRD
 Director/Board Member 70 15-06-11
Yu Ling Chan CEO
 Chief Executive Officer 63 98-05-04
Lap-Chee Tsui BRD
 Director/Board Member 73 15-06-11
Yee Wai Man BRD
 Director/Board Member 58 97-12-31
Kwok Keung Leung BRD
 Director/Board Member 68 23-06-13

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 395,897,275 186,308,134 ( 47.06 %) 0 47.06 %

Shareholders

NameEquities%Valuation
Yu Ling Chan
35.80 %
141,730,841 35.80 % 15 M $
Chan Yu Ling Abraham Family
19.54 %
77,349,750 19.54 % 8 M $
Norimoto Hisayoshi
0.0935 %
370,000 0.0935 % 39 239 $
Kwok Wah Ho
0.005052 %
20,000 0.005052 % 2 121 $
Lim Kin Leung
0.005052 %
20,000 0.005052 % 2 121 $
Lap-Chee Tsui
0.005052 %
20,000 0.005052 % 2 121 $
Kam Biu Tsoi
0.000000 %
0 0.000000 % - $
Eddie Chan
0.000000 %
0 0.000000 % - $

Company contact information

PuraPharm Corp. Ltd.

Unit 201–207, 2/F Wireless Centre, Phase One

, Hong Kong

+

http://www.purapharm.com
address PuraPharm Corporation Limited(1498)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Alternative Medicine

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

1st Jan change Capi.
PURAPHARM CORPORATION LIMITED Stock PuraPharm Corporation Limited
-17.78% 38.34M
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+37.12% 6.02B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-14.61% 4.55B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-10.58% 3.13B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+0.86% 3.07B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-0.94% 2.57B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+36.18% 1.82B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-10.82% 1.63B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
-4.89% 1.57B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-12.50% 1.54B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. 1498 Stock
  4. Company PuraPharm Corporation Limited